PropertyValue
?:abstract
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have an important role in treating SARS-CoV-2 infection and its long-lasting effects.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.tcm.2020.10.005
?:doi
?:journal
  • Trends_Cardiovasc_Med
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/4f63f43a11273febdc3122502fecdb94ccd08b7b.json; document_parses/pdf_json/e4e450b22a3a9fe659459e52221f72facb982d40.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7556303.xml.json
?:pmcid
?:pmid
?:pmid
  • 33068723.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • COVID-19 – A vascular disease
?:type
?:year
  • 2020-10-14

Metadata

Anon_0  
expand all